Understanding the Acceptability of Broadly Neutralizing Antibodies for HIV Prevention Among At-Risk Populations and Feasibility Considerations for Product Introduction in India: Protocol for a Qualitative Study.

MLA

Mukherjee, Joyeeta, et al. “Understanding the Acceptability of Broadly Neutralizing Antibodies for HIV Prevention Among At-Risk Populations and Feasibility Considerations for Product Introduction in India: Protocol for a Qualitative Study.” JMIR Research Protocols, vol. 13, Feb. 2024, p. e47700. EBSCOhost, https://doi.org/10.2196/47700.

APA

Mukherjee, J., Rawat, S., Ul Hadi, S., Aggarwal, P., Chakrapani, V., Rath, P., Manchi, P., Aylur, S., Malhotra, S., Keane, M., & Gangaramany, A. (2024). Understanding the Acceptability of Broadly Neutralizing Antibodies for HIV Prevention Among At-Risk Populations and Feasibility Considerations for Product Introduction in India: Protocol for a Qualitative Study. JMIR Research Protocols, 13, e47700. https://doi.org/10.2196/47700

Chicago

Mukherjee, Joyeeta, Shruta Rawat, Saif Ul Hadi, Pritha Aggarwal, Venkatesan Chakrapani, Pratyasha Rath, Pallavi Manchi, et al. 2024. “Understanding the Acceptability of Broadly Neutralizing Antibodies for HIV Prevention Among At-Risk Populations and Feasibility Considerations for Product Introduction in India: Protocol for a Qualitative Study.” JMIR Research Protocols 13 (February): e47700. doi:10.2196/47700.